IM Cannabis Corp

IMCC | $0.611 -15.93% -18.95% 600K

(0.0% 1d) (106.6% 1m) (40.3% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-62.84% volume)
Earnings Calendar: 2023-11-13
Market Cap: $ 8,181,016
https://imcannabis.com
Sec Filling | Patents | 2020 employees

IMC is an MCO in the medical cannabis sector headquartered in Israel and with operations In Israel and Germany. Over the past decade, the Company believes that the IMC brand has become synonymous with quality and consistency in the Israeli medical cannabis market. The Company has also expanded its business to offer intellectual property-related services to the medical cannabis industry. In Europe, IMC operates through Adjupharm GmbH ("Adjupharm"), a German-based subsidiary and EU-GMP certified medical cannabis distributor. IMC's European presence is augmented by strategic alliances with various pan-European EU-GMP cultivators and distributors to capitalize on the increased demand for medical cannabis products in Europe and bring the IMC brand and its product portfolio to European patients.

israel brands cannabis

add to watch list Paper trade email alert is off

Press-releases

IMC Reschedules the Final Payment of the Oranim Pharmacy Acquisition
Published: 2024-01-12 (Crawled : 12:00) - prnewswire.com
IMCC | $0.611 -15.93% -18.95% 600K

Manufacturing

| 235.71% | O: 8.75% H: 5.09% C: -3.45%
pharmacy payment acquisition

IMC Announces the Conclusion of the Planning and Construction Legal Proceedings
Published: 2024-01-02 (Crawled : 12:00) - prnewswire.com
IMCC | $0.611 -15.93% -18.95% 600K

Manufacturing

| 163.31% | O: 0.03% H: 0.81% C: -4.76%
construction

New Israeli cannabis regulation, facilitating access for many new patients, scheduled for December 29, 2023, has been postponed by three months; Israeli Ministry of Health published a new report showing a surge in new medical cannabis patients in November 2023
Published: 2023-12-08 (Crawled : 12:00) - prnewswire.com
IMCC | $0.611 -15.93% -18.95% 600K

Manufacturing

| 153.3% | O: -0.16% H: 2.51% C: -2.02%
cannabis report health medical

IM Cannabis to Report Third Quarter 2023 Financial Results on Monday, November 13 at 9:00am ET
Published: 2023-11-08 (Crawled : 12:00) - prnewswire.com
IMCC | $0.611 -15.93% -18.95% 600K

Manufacturing

| 104.35% | O: 4.35% H: 0.0% C: -5.62%
cannabis report financial results

IM Cannabis Releases a Message from the CEO about the Israel-Hamas War and announces securing C$1,390,000 in Short-Term Debt
Published: 2023-10-13 (Crawled : 11:00) - prnewswire.com
IMCC | $0.611 -15.93% -18.95% 600K

Manufacturing

| 59.84% | O: 7.74% H: 2.51% C: -0.71%
cannabis ceo

IMC welcomes new Israeli cannabis regulations which are about to change significantly, facilitating access for many new patients
Published: 2023-08-11 (Crawled : 11:00) - prnewswire.com
IMCC | $0.611 -15.93% -18.95% 600K

Manufacturing

| -5.05% | O: 0.0% H: 13.79% C: 3.03%
cannabis change

IM Cannabis to Report Second Quarter 2023 Financial Results on Monday, August 14 at 9:00am ET
Published: 2023-08-08 (Crawled : 11:00) - prnewswire.com
IMCC | $0.611 -15.93% -18.95% 600K

Manufacturing

| -6.93% | O: 1.98% H: 4.6% C: 0.49%
cannabis report financial results

IM Cannabis Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency
Published: 2023-08-04 (Crawled : 20:00) - prnewswire.com
IMCC | $0.611 -15.93% -18.95% 600K

Manufacturing

| Email alert Add to watchlist
cannabis nasdaq